EAN News

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2026.

EAN President-Elect, Kailash Bhatia, looks ahead to the forthcoming EAN Board elections and activities for Brain Awareness Week.

Welcome to the March 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

A Headache Theater networking session at the 19th European Headache Congress in December highlighted how early-career clinicians and researchers are helping shape the future of headache medicine in Europe.

Ready for a new and rewarding challenge? Following the elections in June, the new EAN Board will be looking for new officers to join the ranks of its committees and working groups. Apply now!

Large prospective analysis examining association of long-term coffee and tea intake with incident dementia, and with subjective and objective cognitive outcomes.

The call is now open for the nomination of candidates for the EAN Board Election 2026.

Ghent University, in collaboration with the EAN, will host the EAN Brain Health Strategy Chair Symposium on 5 March 2026, bringing together leading experts to highlight the urgent importance of brain health across Europe.

EAN celebrates unprecedented scientific engagement this year. Don't miss the chance to take part in the most dynamic and inspiring neurology congress of the year.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2026.

EAN Education Committee Chair, Prof. Nathalie Nasr, gives an update on the academic path provided by the EAN’s educational activities.

Welcome to the February 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Results of a multicentre, placebo-controlled trial evaluating the efficacy and safety of fremanezumab in children and adolescents aged 6–17 years with episodic migraine.

The European Journal of Neurology is inviting researchers to submit original research articles, short communications, reviews, commentaries, and letters for a special issue on Environmental Influences in Neurology.

eanNews editor Benedetta Bodini talks to Elena Ruiz de la Torre, Executive Director of the European Migraine & Headache Alliance as part of our series of interviews with patient representatives on EAN Scientific Panels.